290 results on '"McDonnell, Timothy J."'
Search Results
2. High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL
3. A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL
4. Lymphoplasmacytic lymphoma with IgG or IgA paraprotein: a study of 29 cases including cases that can mimic plasma cell neoplasms
5. EZH2 expression is associated with inferior overall survival in mantle cell lymphoma
6. Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis
7. Cytogenetics-based risk prediction of blastic transformation of chronic myeloid leukemia in the era of TKI therapy
8. High Metastatic Potential in Mice Inheriting a Targeted p53 Missense Mutation
9. Tumor Suppression and Apoptosis of Human Prostate Carcinoma Mediated by a Genetic Locus within Human Chromosome 10pter-q11
10. The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.
11. Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP
12. Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors
13. B-acute lymphoblastic leukemia/lymphoma (B-ALL) with precedent or concurrent myelodysplastic syndrome (MDS) with deletion 5q
14. Apoptosis and Cancer : Pathogenic and Therapeutic Implications
15. Evaluating the Impact of Lab-Based Eligibility Criteria By Race/Ethnicity in Frontline Clinical Trials for Diffuse Large B-Cell Lymphoma (DLBCL): A LEO Cohort Analysis
16. Comparison of outpatient and home‐based exercise training programmes for COPD: A systematic review and meta‐analysis
17. Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies
18. Therapy-related myeloid neoplasms following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
19. HDM4 is overexpressed in mantle cell lymphoma and its inhibition induces p21 expression and apoptosis
20. The bcl-2 Oncogene: Apoptosis and Neoplasia
21. PI3 Kinase inhibition on TRAIL-induced apoptosis correlates with androgen-sensitivity and p21 expression in prostate cancer cells
22. Induction of p53-mediated transcription and apoptosis by exportin-1 (XPO1) inhibition in mantle cell lymphoma
23. The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death
24. Diagnosis to Treatment Interval (DTI) Informs Outcomes across Subtypes of Aggressive B-Cell Lymphoma
25. Real-World Impact of Differences in the World Health Organization (WHO) Classification and International Consensus Classification (ICC) Systems on the Diagnosis of Non-Hodgkin Lymphoma: An Analysis from the LEO Cohort Study
26. HDM4 (HDMX) is widely expressed in adult pre-B acute lymphoblastic leukemia and is a potential therapeutic target
27. Selective inhibition of STAT3 induces apoptosis and G1 cell cycle arrest in ALK-positive anaplastic large cell lymphoma
28. GSH depletion enhances adenoviral bax-induced apoptosis in lung cancer cells
29. Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiation
30. A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cells
31. Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma
32. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
33. The function of multiple IκB : NF-κB complexes in the resistance of cancer cells to Taxol-induced apoptosis
34. Identification of Cell Cycle Regulatory Genes as Principal Targets of p53-mediated Transcriptional Repression
35. Characterization of 4 mantle cell lymphoma cell lines: establishment of an in vitro study model
36. TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2
37. Bcl-2 accelerates multistep prostate carcinogenesis in vivo
38. The impact of bcl-2 expression and bax deficiency on prostate homeostasis in vivo
39. A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
40. Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53
41. Molecular Regulation of Cell Death and Therapeutic Strategies for Cell Death Induction in Prostate Carcinoma
42. Human keratin-1.bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation
43. Selenium and Vitamin E: Cell Type– and Intervention-Specific Tissue Effects in Prostate Cancer
44. Combined laser capture microdissection and serial analysis of gene expression from human tissue samples
45. Sonic Hedgehog Induces Epidermal Growth Factor Dependent Matrix Infiltration in HaCaT Keratinocytes
46. Bcl-2 inhibits p53 nuclear import following DNA damage
47. Resistance to radiation-induced apoptosis in Bcl-2-expressing cells is reversed by depleting cellular thiols
48. Bilateral olecranon fracture as first presentation of sarcoidosis: Case report and review of the literature
49. Bcl-2 protects cells from cytokine-induced nitric-oxide-dependent apoptosis
50. Cooperation of Ha-ras and Bcl-2 during multistep skin carcinogenesis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.